Prolonged expression or activation of YAP in the liver promotes the emergence of tumoral lesions with features of either hepatocellular carcinoma or cholangiocarcinomas, thus demonstrating the oncogenic potential of YAP (8,9,11–15). The gene discussed is YAP1; the disease is hepatocellular carcinoma.